• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

有卒中病史的心房颤动患者消融治疗的临床安全性和有效性

Clinical Safety and Efficacy of Ablation for Atrial Fibrillation Patients With a History of Stroke.

作者信息

Song Zi-Liang, Wu Shao-Hui, Zhang Dao-Liang, Jiang Wei-Feng, Qin Mu, Liu Xu

机构信息

Department of Cardiology, Shanghai Chest Hospital, Shanghai Jiaotong University, Shanghai, China.

出版信息

Front Cardiovasc Med. 2021 Mar 10;8:630090. doi: 10.3389/fcvm.2021.630090. eCollection 2021.

DOI:10.3389/fcvm.2021.630090
PMID:33778023
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7987660/
Abstract

To evaluate the clinical safety and efficacy of radiofrequency catheter ablation for atrial fibrillation patients with a history of stroke. A total of 116 symptomatic, drug-refractory AF patients with a history of stroke, and 1:2 matched patients without a history of stroke were enrolled. Of these, 28 cases occurred stroke within 3 months (Group 1), 88 cases with stroke history longer than 3 months (Group 2), and 232 cases without stroke (Group 3). PVI was performed in all patients, extended to ablation of linear lesions ablation. The periprocedural stroke rates and other procedure-related in-hospital complications did not differ significantly among the three groups. The maintenance rate of SR after the procedure showed no significant difference ( = 0.333), 52.7, 66.4, and 70.7% in Group 1, 2, and 3, respectively. Furthermore, the comparison between a history of stroke and those without it were also shown no significant difference ( = 0.351). Radiofrequency ablation for AF patients occurred stroke, even within 3 months is safe and effective, without higher periprocedural complication rate and recurrence rate.

摘要

评估射频导管消融术对有卒中病史的心房颤动患者的临床安全性和有效性。共纳入116例有卒中病史的症状性、药物难治性房颤患者,以及按1:2匹配的无卒中病史患者。其中,28例在3个月内发生卒中(第1组),88例卒中病史超过3个月(第2组),232例无卒中(第3组)。所有患者均行肺静脉隔离术,并扩展至线性病变消融。三组围手术期卒中发生率及其他与手术相关的院内并发症无显著差异。术后窦性心律维持率无显著差异(=0.333),第1、2、3组分别为52.7%、66.4%和70.7%。此外,有卒中病史者与无卒中病史者之间的比较也无显著差异(=0.351)。对有卒中病史的房颤患者进行射频消融术,即使在3个月内也是安全有效的,围手术期并发症发生率和复发率不会更高。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6c2/7987660/d8315a62bb74/fcvm-08-630090-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6c2/7987660/d8315a62bb74/fcvm-08-630090-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6c2/7987660/d8315a62bb74/fcvm-08-630090-g0001.jpg

相似文献

1
Clinical Safety and Efficacy of Ablation for Atrial Fibrillation Patients With a History of Stroke.有卒中病史的心房颤动患者消融治疗的临床安全性和有效性
Front Cardiovasc Med. 2021 Mar 10;8:630090. doi: 10.3389/fcvm.2021.630090. eCollection 2021.
2
Catheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy: atrial fibrillation type determines the success rate.肥厚型心肌病患者心房颤动的导管消融:心房颤动类型决定成功率。
Kardiol Pol. 2013;71(1):17-24.
3
Safety and efficacy of contemporary catheter ablation for atrial fibrillation patients with a history of cardioembolic stroke in the era of direct oral anticoagulants.在直接口服抗凝剂时代,当代导管消融术治疗有心脏栓塞性卒中病史的房颤患者的安全性和有效性。
J Cardiol. 2017 Jul;70(1):86-91. doi: 10.1016/j.jjcc.2016.10.001. Epub 2016 Nov 3.
4
Periprocedural stroke and bleeding complications in patients undergoing catheter ablation of atrial fibrillation with different anticoagulation management: results from the Role of Coumadin in Preventing Thromboembolism in Atrial Fibrillation (AF) Patients Undergoing Catheter Ablation (COMPARE) randomized trial.不同抗凝管理的房颤导管消融患者围术期卒中与出血并发症:来自华法林在房颤(AF)患者导管消融中预防血栓栓塞(COMPARE)随机试验的作用(Role of Coumadin in Preventing Thromboembolism in Atrial Fibrillation (AF) Patients Undergoing Catheter Ablation,COMPARE)的研究结果。
Circulation. 2014 Jun 24;129(25):2638-44. doi: 10.1161/CIRCULATIONAHA.113.006426. Epub 2014 Apr 17.
5
Complication Rates of Catheter Ablation of Atrial Fibrillation in Patients Aged ≥75 Years versus <75 Years-Results from the German Ablation Registry.≥75岁与<75岁心房颤动患者导管消融的并发症发生率——来自德国消融注册研究的结果
J Cardiovasc Electrophysiol. 2017 Mar;28(3):258-265. doi: 10.1111/jce.13142. Epub 2017 Jan 14.
6
Pulmonary vein isolation cryoablation for patients with persistent and long-standing persistent atrial fibrillation: Clinical outcomes from the real-world multicenter observational project.肺静脉隔离冷冻消融治疗持续性和长程持续性心房颤动患者:真实世界多中心观察性研究的临床结果。
Heart Rhythm. 2018 Mar;15(3):363-368. doi: 10.1016/j.hrthm.2017.10.038. Epub 2017 Oct 26.
7
Feasibility and safety of uninterrupted rivaroxaban for periprocedural anticoagulation in patients undergoing radiofrequency ablation for atrial fibrillation: results from a multicenter prospective registry.接受射频消融治疗心房颤动的患者中,不停用利伐沙班进行围手术期抗凝的可行性和安全性:多中心前瞻性注册研究结果。
J Am Coll Cardiol. 2014 Mar 18;63(10):982-8. doi: 10.1016/j.jacc.2013.11.039. Epub 2014 Jan 8.
8
Ganglionated plexus ablation vs linear ablation in patients undergoing pulmonary vein isolation for persistent/long-standing persistent atrial fibrillation: a randomized comparison.神经丛消融与线性消融在持续性/长程持续性心房颤动患者行肺静脉隔离术中的对比:一项随机比较。
Heart Rhythm. 2013 Sep;10(9):1280-6. doi: 10.1016/j.hrthm.2013.04.016. Epub 2013 Apr 19.
9
Safety and efficacy of early radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation complicated with amiodarone-induced thyrotoxicosis.早期射频导管消融治疗阵发性心房颤动合并胺碘酮所致甲状腺毒症患者的安全性和有效性
Cardiol J. 2016;23(4):416-21. doi: 10.5603/CJ.a2016.0029. Epub 2016 Jun 14.
10
Efficacy and Safety of Uninterrupted Low-Intensity Warfarin for Radiofrequency Catheter Ablation of Atrial Fibrillation in the Elderly.不间断低强度华法林用于老年房颤患者射频导管消融的疗效与安全性
Ann Pharmacother. 2017 Sep;51(9):735-742. doi: 10.1177/1060028017712532. Epub 2017 Jun 2.

引用本文的文献

1
Cardiocerebrovascular benefits of early rhythm control in patients with atrial fibrillation detected after stroke: a systematic review and meta-analysis.卒中后检测到的心房颤动患者早期节律控制的心血管益处:一项系统评价和荟萃分析。
Front Cardiovasc Med. 2024 May 16;11:1391534. doi: 10.3389/fcvm.2024.1391534. eCollection 2024.
2
Fighting Cardiac Thromboembolism during Transcatheter Procedures: An Update on the Use of Cerebral Protection Devices in Cath Labs and EP Labs.经导管手术期间对抗心脏血栓栓塞:导管实验室和心脏电生理实验室中脑保护装置使用的最新进展
Life (Basel). 2023 Aug 28;13(9):1819. doi: 10.3390/life13091819.

本文引用的文献

1
Early Rhythm-Control Therapy in Patients with Atrial Fibrillation.心房颤动患者的早期节律控制治疗。
N Engl J Med. 2020 Oct 1;383(14):1305-1316. doi: 10.1056/NEJMoa2019422. Epub 2020 Aug 29.
2
2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC.2020年欧洲心脏病学会(ESC)与欧洲心胸外科学会(EACTS)合作制定的心房颤动诊断和管理指南:欧洲心脏病学会(ESC)心房颤动诊断和管理特别工作组,由ESC欧洲心律协会(EHRA)特别贡献制定。
Eur Heart J. 2021 Feb 1;42(5):373-498. doi: 10.1093/eurheartj/ehaa612.
3
Safety of Anticoagulation in Patients Treated With Urgent Reperfusion for Ischemic Stroke Related to Atrial Fibrillation.伴有房颤的缺血性脑卒中患者接受紧急再灌注治疗时的抗凝安全性。
Stroke. 2020 Aug;51(8):2347-2354. doi: 10.1161/STROKEAHA.120.030143. Epub 2020 Jul 10.
4
Femoral vascular complications after catheter ablation in the current era: The utility of computed tomography imaging.当代经导管消融术后股血管并发症:计算机断层成像的应用。
J Cardiovasc Electrophysiol. 2020 Jun;31(6):1385-1393. doi: 10.1111/jce.14468. Epub 2020 Apr 13.
5
2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: Executive summary.2017年心房颤动导管消融与外科消融专家共识声明:执行摘要(由心律学会/欧洲心律协会/欧洲心血管病预防与康复协会/亚太心律学会/拉丁美洲心脏电生理与心脏起搏学会发布)
Heart Rhythm. 2017 Oct;14(10):e445-e494. doi: 10.1016/j.hrthm.2017.07.009. Epub 2017 Sep 15.
6
Dispersion-guided ablation in conjunction with circumferential pulmonary vein isolation is superior to stepwise ablation approach for persistent atrial fibrillation.在持续性心房颤动中,与环肺静脉隔离相结合的弥散引导消融优于逐步消融方法。
Int J Cardiol. 2019 Mar 1;278:97-103. doi: 10.1016/j.ijcard.2018.12.051. Epub 2018 Dec 19.
7
Extra pulmonary vein driver mapping and ablation in paroxysmal atrial fibrillation by electrogram dispersion analysis.肺静脉外驱动标测和房颤时电信号离散度分析指导下的消融。
J Cardiovasc Electrophysiol. 2019 Feb;30(2):164-170. doi: 10.1111/jce.13784. Epub 2018 Nov 21.
8
Five-year impact of catheter ablation for atrial fibrillation in patients with a prior history of stroke.房颤合并卒中史患者导管消融术后 5 年的影响。
J Cardiovasc Electrophysiol. 2018 Feb;29(2):221-226. doi: 10.1111/jce.13390. Epub 2017 Dec 13.
9
Safety and efficacy of contemporary catheter ablation for atrial fibrillation patients with a history of cardioembolic stroke in the era of direct oral anticoagulants.在直接口服抗凝剂时代,当代导管消融术治疗有心脏栓塞性卒中病史的房颤患者的安全性和有效性。
J Cardiol. 2017 Jul;70(1):86-91. doi: 10.1016/j.jjcc.2016.10.001. Epub 2016 Nov 3.
10
Early start of DOAC after ischemic stroke: Risk of intracranial hemorrhage and recurrent events.缺血性卒中后早期启动直接口服抗凝剂:颅内出血和复发事件的风险
Neurology. 2016 Nov 1;87(18):1856-1862. doi: 10.1212/WNL.0000000000003283. Epub 2016 Sep 30.